COR(COR)
COR
Consensus
Buy3.85 / 513 ratings · Buy 11 · Hold 2
Price vs analyst targets
Revenue and EPS estimates
| Reported | Consensus estimates | |||||||
|---|---|---|---|---|---|---|---|---|
| Fiscal period | FY2024Sep '24 | FY2025Sep '25 | FY2026Sep '26 | FY2027Sep '27 | FY2028Sep '28 | FY2029Sep '29 | FY2030Sep '30 | FY2031Sep '31 |
| Revenue (B) | 293.96 | 321.33 | 337.40 | 352.39 | 368.42 | 388.14 | 409.83 | 426.39 |
| Growth YoY | +12.1% | +9.3% | +5.0% | +4.4% | +4.5% | +5.4% | +5.6% | +4.0% |
| High estimate | – | – | – | 354.03 | 372.12 | 396.33 | 414.08 | 430.82 |
| Low estimate | – | – | – | 351.48 | 363.64 | 382.95 | 405.99 | 422.40 |
| Analysts | – | – | – | 7 | 6 | 5 | 4 | 3 |
| EPS, adjusted | 13.76 | 15.99 | 17.97 | 19.69 | 21.70 | 24.33 | 27.53 | 31.66 |
| Growth YoY | +14.8% | +16.2% | +12.4% | +9.5% | +10.2% | +12.1% | +13.2% | +15.0% |
| High estimate | – | – | – | 19.88 | 22.12 | 26.79 | 27.90 | 32.09 |
| Low estimate | – | – | – | 19.51 | 21.26 | 21.87 | 27.19 | 31.27 |
| Analysts | – | – | – | 6 | 6 | 3 | 1 | 2 |
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
13 firms active in the last 12 months
| Firm | Analyst | Rating | Prev rating | Target | Prev target | Chg | Upside | Date |
|---|---|---|---|---|---|---|---|---|
| Wells Fargo | Stephan Baxter | Overweight · Aug 2026 | Overweight | $400.00 | $331.00 | +21% | +14% | Nov 17 |
| JP Morgan | – | Overweight | Overweight | – | – | – | – | Nov 10 |
| Evercore ISI Group | – | Outperform | Outperform | $350.00 | $360.00 | −3% | 0% | Nov 5 |
| Leerink Partners | – | Outperform | Outperform | – | – | – | – | Nov 5 |
| Morgan Stanley | – | Overweight | Overweight | $346.00 | $342.00 | +1% | −1% | Oct 30 |
| Bank of America Securities | – | Neutral · Jun 2026 | Neutral | $345.00 | $245.00 | +41% | −1% | Oct 22 |
| Robert W. Baird | Eric Coldwell | Outperform | Outperform | $375.00 | $370.00 | +1% | +7% | Oct 22 |
| Argus Research | David Toung | Buy | Buy | $380.00 | $270.00 | +41% | +9% | Oct 20 |
| UBS | Kevin Caliendo | Buy | Buy | $400.00 | $430.00 | −7% | +14% | Oct 16 |
| RBC Capital | Ryan Halsted | Sector Perform | Sector Perform | $330.00 | – | – | −6% | Sep 8 |
| Barclays | – | Overweight | Overweight | $350.00 | $425.00 | −18% | 0% | Jun 10 |
| Citigroup | – | Buy | Buy | – | – | – | – | May 7 |
| Jefferies | Brian Tanquilut | Buy | Hold | $440.00 | – | – | +26% | Jan 22 |
Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data
Explore More
COR Financial Metrics
Explore 130+ historical metrics & ratios
Healthcare Stocks
More Healthcare stocks
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance